RE:RE:Doom and gloom comes from shorts
marxmath i dont really blame management for everything..i blame mark for buying the cinven portfolio and writing down almost 50% 2 years later..i still dont get the write down. When u see the wow scripts most of drugs are doing well. They almost generate 20 % of annual revenue close to 200 million in annual sales. Amco is doing well ..and was growing at 8% every quarter hence the cinven payment. Brexit should have never happened but did..and the pound was decimated..its all bad luck. However the international segment of amco sells to over 100 countries, they now have offices in china and india as well. 2 biggest markets in the world.once they start figuring that out sales will double in 2 years. Dont forget they acquired this company less then 1 year ago..thats nothing.. they need to work on it and fine tune it properly.They have the cash, they are profitable and now are trading at liquidation valuation. The shares are at almost $ 3.75 us a share, i dont think there is a pharma company out there generating almost 900 million in revenue trading at less then 1 times ebidita. Market is at 10-12 times. Hostile takeover is possible. Someone like allergan with a huge share price could take this out by printing 1 million shares. They got almost 40 billion from teva, they could use wipe out the debt and make 300 million net every year by doing so..